Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2020

01-01-2020 | Rectal Cancer | 2019 SSAT Plenary Presentation

The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients

Authors: Maude Trepanier, Tiffany Paradis, Araz Kouyoumdjian, Teodora Dumitra, Patrick Charlebois, Barry S. Stein, A. Sender Liberman, Kevin Schwartzman, Franco Carli, Gerald M. Fried, Liane S. Feldman, Lawrence Lee

Published in: Journal of Gastrointestinal Surgery | Issue 1/2020

Login to get access

Abstract

Introduction

Treatment delay may have detrimental effects on cancer outcomes. The impact of longer delays on colorectal cancer outcomes remains poorly described. The objective of this study was to determine the effect of delays to curative-intent surgical resection on survival in colorectal cancer patients.

Methods

All adult patients undergoing elective resection of primary non-metastatic colorectal adenocarcinoma from January 2009 to December 2014 were reviewed. Treatment delays were defined as the time from tissue diagnosis to definitive surgery, categorized as < 4, 4 to < 8, and ≥ 8 weeks. Primary outcomes were 5-year disease-free (DFS) and overall survival (OS). Statistical analysis included Kaplan–Meier curves and Cox regression models.

Results

A total of 408 patients were included (83.2% colon;15.8% rectal) with a mean follow-up of 58.4 months (SD29.9). Fourteen percent (14.0%) of patients underwent resection < 4 weeks, 40.0% 4 to < 8 weeks, and 46.1% ≥ 8 weeks. More rectal cancer patients had treatment delay ≥ 8 weeks compared with colonic tumors (69.8% vs. 41.4%, p < 0.001). Cumulative 5-year DFS and OS were similar between groups (p = 0.558; p = 0.572). After adjusting for confounders, surgical delays were not independently associated with DFS and OS.

Conclusions

Treatment delays > 4 weeks were not associated with worse oncologic outcomes. Delaying surgery to optimize patients can safely be considered without compromising survival.
Literature
1.
go back to reference Tjandra J, Chan M. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50(11):1783-99.CrossRef Tjandra J, Chan M. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50(11):1783-99.CrossRef
2.
go back to reference Nelson H, Sargent DJ, Wieand HS, Flesh-man J, Anvari M, Stryker SJ et al. A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer. N Engl J Med. 2004;350:2050-9.CrossRef Nelson H, Sargent DJ, Wieand HS, Flesh-man J, Anvari M, Stryker SJ et al. A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer. N Engl J Med. 2004;350:2050-9.CrossRef
10.
go back to reference Simunovic M, Rempel E, Thériault ME, Baxter NN, Virnig BA, Meropol NJ et al. Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg. 2009;52(4):E79-E86.PubMedPubMedCentral Simunovic M, Rempel E, Thériault ME, Baxter NN, Virnig BA, Meropol NJ et al. Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg. 2009;52(4):E79-E86.PubMedPubMedCentral
21.
23.
go back to reference Gillis C, Li C, Lee L, Aswathi R, Augustin B, Gamsa A et al. Prehabilitation versus Rehabilitation: A Randomized Control Trial in Patients Undergoing Colorectal Resection for Cancer. Anesthesiology. 2014;121(5):937-47.CrossRef Gillis C, Li C, Lee L, Aswathi R, Augustin B, Gamsa A et al. Prehabilitation versus Rehabilitation: A Randomized Control Trial in Patients Undergoing Colorectal Resection for Cancer. Anesthesiology. 2014;121(5):937-47.CrossRef
28.
go back to reference Clavien P, Sanabria J, Strasberg S. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111(5):518-26.PubMed Clavien P, Sanabria J, Strasberg S. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111(5):518-26.PubMed
29.
go back to reference Aoyama T, Yamamoto N, Kamiya M, Murakawa M, Tamagawa H, Sawazaki S et al. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy. Anticancer Res. 2018;38(8):4877-82.CrossRef Aoyama T, Yamamoto N, Kamiya M, Murakawa M, Tamagawa H, Sawazaki S et al. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy. Anticancer Res. 2018;38(8):4877-82.CrossRef
30.
go back to reference Steele S, Chang G, Hendren S, Weiser M, Irani J, Buie W et al. Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. Dis Colon Rectum. 2015;58:713-25.CrossRef Steele S, Chang G, Hendren S, Weiser M, Irani J, Buie W et al. Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. Dis Colon Rectum. 2015;58:713-25.CrossRef
31.
go back to reference Amri R, Bordeianou LG, Sylla P, Berger DL. Treatment delay in surgically-treated colon cancer: does it affect outcomes? Ann Surg Oncol. 2014;21(12):3909-16.CrossRef Amri R, Bordeianou LG, Sylla P, Berger DL. Treatment delay in surgically-treated colon cancer: does it affect outcomes? Ann Surg Oncol. 2014;21(12):3909-16.CrossRef
33.
go back to reference Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem Suppl. 1992;16:41-6.CrossRef Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem Suppl. 1992;16:41-6.CrossRef
34.
go back to reference Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251-70.CrossRef Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251-70.CrossRef
36.
go back to reference Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107-14.CrossRef Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107-14.CrossRef
39.
Metadata
Title
The Impact of Delays to Definitive Surgical Care on Survival in Colorectal Cancer Patients
Authors
Maude Trepanier
Tiffany Paradis
Araz Kouyoumdjian
Teodora Dumitra
Patrick Charlebois
Barry S. Stein
A. Sender Liberman
Kevin Schwartzman
Franco Carli
Gerald M. Fried
Liane S. Feldman
Lawrence Lee
Publication date
01-01-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 1/2020
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-019-04328-4

Other articles of this Issue 1/2020

Journal of Gastrointestinal Surgery 1/2020 Go to the issue

Evidence-Based Current Surgical Practice

What’s New in the Management of Incarcerated Hernia